🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
601,32 USD
Máx. histórico
601,32
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
430,02 – 609,99
Variación hoy
+0,87%
Cierre anterior
596,13
Rango de hoy
596,14 – 606,16
Volumen hoy
595.233
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,54 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 22 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 09/09/2024 | 345,41 | 349,35 | 344,02 | 348,71 | +0,89% | 1,54% | 352.300 |
| 06/09/2024 | 349,76 | 351,64 | 345,33 | 345,63 | -1,25% | 1,80% | 275.800 |
| 05/09/2024 | 351,29 | 353,01 | 347,62 | 350,01 | -0,95% | 1,53% | 351.800 |
| 04/09/2024 | 352,65 | 354,95 | 349,57 | 353,37 | +0,28% | 1,53% | 399.100 |
| 03/09/2024 | 362,37 | 366,08 | 352,06 | 352,40 | -3,07% | 3,87% | 509.100 |
| 30/08/2024 | 360,22 | 364,45 | 359,29 | 363,55 | +0,92% | 1,43% | 464.800 |
| 29/08/2024 | 359,84 | 365,48 | 358,45 | 360,22 | +0,11% | 1,95% | 304.300 |
| 28/08/2024 | 353,00 | 365,98 | 351,14 | 359,84 | +3,04% | 4,20% | 455.500 |
| 27/08/2024 | 346,22 | 350,01 | 343,13 | 349,23 | +0,74% | 1,99% | 409.200 |
| 26/08/2024 | 349,20 | 353,14 | 346,15 | 346,67 | -0,39% | 2,00% | 254.900 |
| 23/08/2024 | 348,04 | 349,97 | 344,16 | 348,03 | +0,33% | 1,67% | 198.000 |
| 22/08/2024 | 351,36 | 351,98 | 344,59 | 346,87 | -1,35% | 2,10% | 568.700 |
| 21/08/2024 | 348,93 | 353,50 | 345,43 | 351,61 | +1,36% | 2,31% | 669.700 |
| 20/08/2024 | 348,00 | 353,38 | 340,48 | 346,88 | -0,49% | 3,71% | 660.800 |
| 19/08/2024 | 329,02 | 350,66 | 327,96 | 348,58 | +8,60% | 6,90% | 1.018.600 |
| 16/08/2024 | 323,73 | 323,73 | 316,32 | 320,99 | -0,65% | 2,29% | 878.900 |
| 15/08/2024 | 325,94 | 326,77 | 321,20 | 323,08 | -0,24% | 1,71% | 369.500 |
| 14/08/2024 | 322,32 | 328,18 | 322,02 | 323,87 | +0,09% | 1,91% | 418.300 |
| 13/08/2024 | 333,45 | 338,74 | 317,30 | 323,59 | -3,05% | 6,43% | 622.900 |
| 12/08/2024 | 328,82 | 336,63 | 327,98 | 333,78 | +1,07% | 2,63% | 425.700 |
| 09/08/2024 | 330,15 | 332,77 | 328,54 | 330,26 | -0,24% | 1,28% | 303.800 |
| 08/08/2024 | 324,39 | 331,45 | 321,94 | 331,04 | +2,73% | 2,93% | 333.900 |
| 07/08/2024 | 325,26 | 327,35 | 320,95 | 322,23 | +0,08% | 1,97% | 343.200 |
| 06/08/2024 | 326,00 | 329,15 | 319,71 | 321,96 | -1,15% | 2,90% | 331.700 |
| 05/08/2024 | 316,44 | 326,84 | 314,92 | 325,72 | -0,60% | 3,77% | 540.000 |
| 02/08/2024 | 325,66 | 330,39 | 320,02 | 327,68 | -0,03% | 3,18% | 702.200 |
| 01/08/2024 | 312,29 | 329,98 | 312,00 | 327,79 | +4,63% | 5,76% | 666.500 |
| 31/07/2024 | 320,52 | 325,99 | 310,00 | 313,29 | -7,18% | 4,99% | 939.000 |
| 30/07/2024 | 336,28 | 342,89 | 333,98 | 337,54 | +0,68% | 2,65% | 506.900 |
| 29/07/2024 | 338,00 | 340,63 | 331,90 | 335,27 | -0,87% | 2,58% | 317.800 |